Testosterone Cypionate TRT Protocol: The Complete Dosing, Injection and Monitoring Guide for UK Users
A testosterone cypionate TRT protocol is the foundation of every well-managed hormone replacement programme because Cypionate’s 8-day half-life creates the pharmacokinetic profile that delivers stable serum testosterone with once or twice weekly injections. A 2025 review in Trends in Urology and Men’s Health confirmed that subcutaneous Testosterone Cypionate produces steady serum concentrations with smaller peak-to-trough fluctuations than intramuscular protocols, reducing the oestradiol spikes and haematocrit elevations that drive side effects on less optimised regimens. Testosterone Cypionate 200mg from Intex Pharma UK is supplied at 200mg/mL, the concentration that has been the global TRT standard for decades because it allows precise measurement of the 100 to 200mg weekly doses that TRT requires. This guide covers the complete testosterone cypionate TRT protocol: starting dose, titration, injection frequency, subcutaneous vs intramuscular routes, bloodwork monitoring, oestrogen management, haematocrit safety and when to adjust.
Why Testosterone Cypionate Is the Gold Standard for TRT
Testosterone Cypionate dominates TRT prescribing for three reasons. First, its half-life of approximately 8 days allows practical once-weekly or twice-weekly injection frequency without the extreme peak-to-trough swings that shorter esters produce. Second, 200mg/mL is the concentration that makes typical TRT doses (100 to 200mg weekly) easy to measure with standard syringes: 0.5mL delivers 100mg, 0.75mL delivers 150mg, 1.0mL delivers 200mg. Third, decades of prescribing data have established the safety and efficacy profile of Testosterone Cypionate at TRT doses more thoroughly than any other testosterone formulation.
For bodybuilders transitioning between blast and cruise, Testosterone Cypionate at TRT dose (the cruise) provides the physiological testosterone base that maintains wellbeing, libido, mood and muscle preservation between growth phases. The 200mg/mL concentration is ideal for cruise dosing because measuring 0.5 to 0.75mL is more precise than measuring 0.33 to 0.5mL of a higher-concentration product like Testosterone Enanthate 300mg, reducing the dosing error that accumulates across months of cruising.
Starting Dose and Titration for Testosterone Cypionate TRT
Testosterone Cypionate TRT: Starting Dose by Situation
| Starting Situation | Starting Dose | Volume (200mg/mL) | Titration |
|---|---|---|---|
| First-time TRT (never used testosterone before) | 100 to 120mg/week | 0.5 to 0.6mL/week | Run for 6 to 8 weeks. Draw trough bloodwork. Adjust by 20 to 25mg increments based on serum total T level |
| Coming off a blast cycle (transitioning to cruise) | 125 to 175mg/week | 0.625 to 0.875mL/week | Higher starting dose reflects larger body mass and higher SHBG from prior supraphysiological exposure. Confirm with bloodwork at 6 weeks |
| Switching from NHS/GP-prescribed Sustanon | Match the weekly testosterone dose from your Sustanon protocol (typically 125mg every 3 weeks = ~42mg/week, which most users find subtherapeutic) | Varies; most users increase to 100 to 150mg/week | Begin weekly or twice-weekly Cypionate injections when the last Sustanon dose is clearing (2 weeks post-injection). Titrate based on symptom resolution and trough bloodwork |
| Over 50 or elevated baseline haematocrit | 80 to 100mg/week | 0.4 to 0.5mL/week | Conservative start to monitor haematocrit response. Older men and those with higher baseline haematocrit are more sensitive to erythropoietic stimulation from exogenous testosterone |
Injection Frequency: Why Twice Weekly Is Superior to Once Weekly
Splitting the weekly Testosterone Cypionate dose into two equal injections (Monday/Thursday or Tuesday/Friday) produces measurably more stable serum testosterone than a single weekly injection. A comparative study of 234 hypogonadal men demonstrated that testosterone replacement with lower peak-to-trough ratios produced significantly lower post-therapy oestradiol and haematocrit elevations. Every-3.5-day dosing reduces the supraphysiological peak that drives aromatisation (testosterone converting to oestrogen), reducing the oestradiol spikes that cause water retention, mood swings and gynaecomastia risk. It also reduces the trough that causes the “crash” feeling many users report on days 6 and 7 of a once-weekly protocol.
Once Weekly vs Twice Weekly Testosterone Cypionate TRT
| Parameter | Once Weekly | Twice Weekly (recommended) |
|---|---|---|
| Peak-to-trough ratio | Higher. Large spike day 1 to 2, significant decline by day 6 to 7 | Flatter. Smaller peaks every 3.5 days with less pronounced troughs |
| Oestradiol control | Higher peak oestradiol from larger testosterone spike. More likely to need an AI | Lower peak oestradiol. Many users avoid AI entirely on twice-weekly dosing |
| Haematocrit impact | Higher. Supraphysiological peaks stimulate erythropoiesis more aggressively | Lower. Flatter curve reduces erythropoietic stimulation |
| Mood and energy stability | Users report energy crashes and mood dips on days 6 and 7 | Consistent energy and mood throughout the week |
| Volume per injection at 150mg/week | 0.75mL once | 0.375mL twice (smaller, more comfortable injections) |
Subcutaneous vs Intramuscular: Which Route for Your Testosterone Cypionate TRT Protocol
Subcutaneous (SubQ) injection of Testosterone Cypionate has moved from experimental to mainstream. Clinical data confirms that SubQ produces comparable serum testosterone levels to intramuscular (IM) at equivalent doses, with an even flatter pharmacokinetic curve, lower oestradiol elevation and lower haematocrit response. SubQ uses insulin-gauge needles (29 to 31 gauge) injected into abdominal or thigh fat, which is less painful and less intimidating than IM injection into the glute, quad or delt with a 23 to 25 gauge needle.
SubQ is most practical at TRT doses (0.375 to 0.5mL per injection with twice-weekly dosing) because the small volume absorbs easily from subcutaneous tissue. At higher bodybuilding doses (1.5mL+ per injection), IM remains preferable because larger oil volumes can cause subcutaneous lumps or irritation. For TRT users running Testosterone Cypionate 200mg at 150mg weekly split into two 0.375mL SubQ injections with insulin syringes, the protocol is nearly painless and produces the most stable serum levels available from any injectable testosterone formulation.
Bloodwork Monitoring on a Testosterone Cypionate TRT Protocol
TRT Bloodwork Schedule and Target Ranges
| Marker | Target Range on TRT | Action if Outside Range |
|---|---|---|
| Total Testosterone (trough) | 600 to 900 ng/dL (20 to 31 nmol/L). Draw at trough: morning of injection day, before injecting | Below 500: increase dose by 20 to 25mg/week. Above 1100: reduce dose by 20 to 25mg/week |
| Oestradiol (sensitive LC-MS/MS) | 20 to 40 pg/mL. Must use the sensitive assay, not the standard immunoassay | Above 50 with symptoms (bloating, mood, nipple sensitivity): increase injection frequency before adding AI. If still elevated: low-dose Anastrozole 0.25mg on injection days |
| Haematocrit | Below 52%. Ideally below 50% | Above 52%: donate blood (therapeutic phlebotomy), increase injection frequency to flatten peaks, consider SubQ if currently IM, hydrate aggressively. Above 54%: reduce dose |
| PSA (men over 40) | Below 4.0 ng/mL. Track the rate of change, not just the absolute number | Rising PSA on TRT warrants urological review. TRT does not cause prostate cancer but can accelerate pre-existing conditions |
| Lipids (total cholesterol, HDL, LDL, triglycerides) | HDL above 40 mg/dL (1.0 mmol/L). LDL below 130 mg/dL (3.4 mmol/L) | Suppressed HDL: increase cardio, add omega-3 (2 to 4g EPA/DHA daily). TRT at physiological doses has minimal lipid impact compared to supraphysiological cycles |
Oestrogen Management on TRT: Why Most Users Should Avoid AI Unless Bloodwork Demands It
Aromatase inhibitors (Anastrozole, Aromasin) are overprescribed on testosterone cypionate TRT protocols. At physiological TRT doses with twice-weekly injection frequency, most users maintain oestradiol within the 20 to 40 pg/mL range without any AI. Oestrogen is not the enemy: it is essential for libido, bone density, cardiovascular protection and cognitive function. Crashing oestrogen with unnecessary AI use produces joint pain, low mood, brain fog and erectile dysfunction that users then mistakenly attribute to their testosterone dose being wrong.
The correct approach is to optimise injection frequency and route first (twice-weekly SubQ produces the lowest oestradiol elevation for any given testosterone dose), then check the sensitive oestradiol assay (LC-MS/MS, not the standard immunoassay which is unreliable in men), and only introduce low-dose AI (0.25mg Anastrozole on injection days) if oestradiol is above 50 pg/mL with symptoms. If oestradiol is elevated but you feel fine, do not add an AI. Symptom-driven management protects the benefits that oestrogen provides while addressing the specific problems that excess causes. Users who ran Nolvadex 20mg during a previous cycle for gynaecomastia prevention can continue it at 10mg daily on TRT if nipple sensitivity persists, as it blocks oestrogen selectively at breast tissue without reducing systemic oestrogen levels.
Run baseline bloodwork before starting any testosterone cypionate TRT protocol. Repeat at 6 to 8 weeks (to confirm dose is producing target levels), then every 3 to 6 months for ongoing monitoring. For the complete bloodwork guide, see the pre-cycle bloodwork guide and the testosterone bloodwork interpretation guide. Users running HCG 5000IU alongside TRT for fertility preservation should monitor oestradiol more frequently, as HCG-driven intratesticular aromatisation adds to the oestrogen load. See the testicular atrophy prevention guide for the HCG protocol.
Available now at Intex Pharma UK
Intex Pharma Testosterone Cypionate 200mg: in stock, £37.00, same day despatch
Janoshik verified, 200mg/mL in a 10mL multi-dose vial. The TRT-precision testosterone. Use code WELCOME20 for 20% off your first order over £200.
Testosterone Cypionate TRT Protocol: Frequently Asked Questions
What dose of Testosterone Cypionate should I start TRT at?
100 to 120mg per week for first-time TRT users, split into two injections of 0.25 to 0.3mL every 3.5 days. Run for 6 to 8 weeks, draw trough bloodwork (morning of injection day, before injecting) and adjust by 20 to 25mg increments based on serum total testosterone level. Target trough of 600 to 900 ng/dL.
Should I inject Testosterone Cypionate once or twice per week?
Twice weekly. Splitting the dose into two injections every 3.5 days produces a flatter serum curve, reducing oestradiol spikes, haematocrit elevation and the energy crash that many users experience on days 6 and 7 of a once-weekly protocol. Many users who needed an aromatase inhibitor on once-weekly dosing find they no longer need one after switching to twice-weekly.
Can I inject Testosterone Cypionate subcutaneously?
Yes. Subcutaneous injection at TRT doses produces comparable serum testosterone levels with an even flatter curve, lower oestradiol and lower haematocrit response than intramuscular injection. Use insulin-gauge needles (29 to 31 gauge) into abdominal or thigh fat. SubQ is most practical at volumes under 0.5mL per injection, making it ideal for twice-weekly TRT dosing.
What happens if my haematocrit rises on TRT?
Above 52%: donate blood (therapeutic phlebotomy), increase injection frequency to flatten peaks, switch to subcutaneous injection if currently intramuscular and hydrate aggressively. Above 54%: reduce the testosterone dose. Haematocrit elevation is the most common dose-limiting side effect of TRT and must be monitored at every bloodwork check.
Do I need HCG alongside Testosterone Cypionate TRT?
If fertility preservation matters to you, yes. Exogenous testosterone suppresses LH and FSH, which stops intratesticular testosterone production and spermatogenesis. HCG at 250 to 500IU twice weekly maintains testicular function and sperm production during TRT. If fertility is not a concern, HCG is optional but prevents testicular atrophy which some users find cosmetically and psychologically important.
Is Intex Pharma Testosterone Cypionate 200mg third-party tested?
Yes. Every batch is independently tested by Janoshik Analytical for compound identity, concentration and sterility. Accurately dosed testosterone is essential for stable serum levels on TRT. Verify the Certificate of Analysis at the Intex Pharma COA guide.